Showing results (971-980 of 5,480) with videos related to
Sort By:
Pageof 548
Pharmacotherapy|October 20, 2005
Quetiapine use in a patient with chronic schizophrenia and severe parkinsonismSteven C Stoner, Jessica W Lea, Angel L Wolf, et al.Pharmacotherapy|January 1, 1986
Cardiac conduction abnormalities and atrial arrhythmias associated with salicylate toxicityV Mukerji, M A Alpert, G C Flaker, et al.Pharmacotherapy|July 1, 1986
Bethanidine sulfate in paroxysmal ventricular tachycardia: toxicity and antifibrillatory actionsJ L Bauman, J Gallastegui, D Prechel, et al.Pharmacotherapy|June 10, 2025
Transdermal rivastigmine as a therapeutic option in severe diphenhydramine-induced anticholinergic toxicity: A case report and literature reviewBrian W Gilbert, Ruben D Santiago, Joel B Huffman, et al.Pharmacotherapy|June 17, 2025
Heterogeneous effects of sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors on nephrolithiasis in older adults with type 2 diabetesRotana M Radwan, Wenxi Huang, Yujia Li, et al.Pharmacotherapy|July 23, 2025
Intraperitoneal Granisetron for Post-Laparoscopic Cholecystectomy Pain Management: A Double-Blinded, Randomized Controlled TrialHoda Mohamed Bayoumi, Doaa Hamed Abdelaziz, Sherif Boraii, et al.Pharmacotherapy|June 21, 2025
Cefepime-taniborbactam: Ushering in the era of metallo-β-lactamase inhibitionSean R Van Helden, Mohammed Al Musawa, Callan R Bleick, et al.Pharmacotherapy|May 10, 2025
Proton pump inhibitor concomitant use to prevent oxaliplatin-induced peripheral neuropathy: Clinical retrospective cohort studyKeisuke Mine, Takehiro Kawashiri, Kohei Mori, et al.Pharmacotherapy|May 12, 2025
Predictive performance of population pharmacokinetic models in InsightRX® for model-informed precision dosing for CefepimeChristina König, Joseph L Kuti, Andrew J FratoniPageof 548